... | ... | ... | Active substance | Medicinal product name | Pharmaceutical form | Strength | ATC code | Max. price range (€ incl. VAT) | ||
---|---|---|---|---|---|---|---|---|---|---|
Is available (according to the information provided by wholesalers) | Prescription (Pr.) |
Reimbursed medicines reference product |
Bevacizumabum Biosimilar medicine |
Abevmy | Concentrate for solution for infusion | 25 mg/ml |
Is available (according to the information provided by wholesalers) Prescription (Pr.) Reimbursed medicines reference product |
L01FG01 — ANTINEOPLASTIC AGENTS | € 203.43 | skatīt informāciju par zālēm un iepakojumiem |
Not available (according to the information provided by wholesalers) | Prescription (Pr.) | Bevacizumabum Biosimilar medicine |
Abevmy | Concentrate for solution for infusion | 25 mg/ml |
Not available (according to the information provided by wholesalers) Prescription (Pr.) |
L01FG01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Is available (according to the information provided by wholesalers) | Prescription (Pr.) |
Reimbursed medicines reference product |
Bevacizumabum Biosimilar medicine |
Abevmy | Concentrate for solution for infusion | 25 mg/ml |
Is available (according to the information provided by wholesalers) Prescription (Pr.) Reimbursed medicines reference product |
L01FG01 — ANTINEOPLASTIC AGENTS | € 747.59 | skatīt informāciju par zālēm un iepakojumiem |
Not available (according to the information provided by wholesalers) | Prescription (Pr.) | Bevacizumabum Biosimilar medicine |
Abevmy | Concentrate for solution for infusion | 25 mg/ml |
Not available (according to the information provided by wholesalers) Prescription (Pr.) |
L01FG01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.) | Bevacizumabum Biosimilar medicine |
Abevmy | Concentrate for solution for infusion | 25 mg/ml |
Not available (according to the information provided by wholesalers) Prescription (Pr.) |
L01FG01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Is available (according to the information provided by wholesalers) | Prescription (Pr.) |
Reimbursed medicines reference product |
Bevacizumabum Biosimilar medicine |
Alymsys | Concentrate for solution for infusion | 25 mg/ml |
Is available (according to the information provided by wholesalers) Prescription (Pr.) Reimbursed medicines reference product |
L01FG01 — ANTINEOPLASTIC AGENTS | € 213.91 | skatīt informāciju par zālēm un iepakojumiem |
Is available (according to the information provided by wholesalers) | Prescription (Pr.) |
Reimbursed medicines reference product |
Bevacizumabum Biosimilar medicine |
Alymsys | Concentrate for solution for infusion | 25 mg/ml |
Is available (according to the information provided by wholesalers) Prescription (Pr.) Reimbursed medicines reference product |
L01FG01 — ANTINEOPLASTIC AGENTS | € 786.70 | skatīt informāciju par zālēm un iepakojumiem |
Is available (according to the information provided by wholesalers) | Prescription (Pr.) |
Next lowest cost medicine |
Bevacizumabum | Avastin | Concentrate for solution for infusion | 25 mg/ml |
Is available (according to the information provided by wholesalers) Prescription (Pr.) Next lowest cost medicine |
L01FG01 — ANTINEOPLASTIC AGENTS | € 340.39 | skatīt informāciju par zālēm un iepakojumiem |
Is available (according to the information provided by wholesalers) | Prescription (Pr.) |
Look for details in the products section |
Bevacizumabum | Avastin | Concentrate for solution for infusion | 25 mg/ml |
Is available (according to the information provided by wholesalers) Prescription (Pr.) Look for details in the products section |
L01FG01 — ANTINEOPLASTIC AGENTS | € 1261.93 | skatīt informāciju par zālēm un iepakojumiem |
Not available (according to the information provided by wholesalers) | Prescription (Pr.) | Bevacizumabum Biosimilar medicine |
Aybintio | Concentrate for solution for infusion | 25 mg/ml |
Not available (according to the information provided by wholesalers) Prescription (Pr.) |
L01FG01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.) | Bevacizumabum Biosimilar medicine |
Aybintio | Concentrate for solution for infusion | 25 mg/ml |
Not available (according to the information provided by wholesalers) Prescription (Pr.) |
L01FG01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.) | Bevacizumabum Biosimilar medicine |
MVASI | Concentrate for solution for infusion | 25 mg/ml |
Not available (according to the information provided by wholesalers) Prescription (Pr.) |
L01FG01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.) | Bevacizumabum Biosimilar medicine |
MVASI | Concentrate for solution for infusion | 25 mg/ml |
Not available (according to the information provided by wholesalers) Prescription (Pr.) |
L01FG01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
MA suspended from the medicinal product register, distribution permitted for a limited time span Not available (according to the information provided by wholesalers) |
Prescription (Pr.) | Bevacizumabum Biosimilar medicine |
Onbevzi | Concentrate for solution for infusion | 25 mg/ml |
MA suspended from the medicinal product register, distribution permitted for a limited time span Not available (according to the information provided by wholesalers) Prescription (Pr.) |
L01FG01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
MA suspended from the medicinal product register, distribution permitted for a limited time span Not available (according to the information provided by wholesalers) |
Prescription (Pr.) | Bevacizumabum Biosimilar medicine |
Onbevzi | Concentrate for solution for infusion | 25 mg/ml |
MA suspended from the medicinal product register, distribution permitted for a limited time span Not available (according to the information provided by wholesalers) Prescription (Pr.) |
L01FG01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Is available (according to the information provided by wholesalers) | Prescription (Pr.) |
Reimbursed medicines reference product |
Bevacizumabum Biosimilar medicine |
Oyavas | Concentrate for solution for infusion | 25 mg/ml |
Is available (according to the information provided by wholesalers) Prescription (Pr.) Reimbursed medicines reference product |
L01FG01 — ANTINEOPLASTIC AGENTS | € 213.91 | skatīt informāciju par zālēm un iepakojumiem |
Not available (according to the information provided by wholesalers) | Prescription (Pr.) |
Reimbursed medicines reference product |
Bevacizumabum Biosimilar medicine |
Oyavas | Concentrate for solution for infusion | 25 mg/ml |
Not available (according to the information provided by wholesalers) Prescription (Pr.) Reimbursed medicines reference product |
L01FG01 — ANTINEOPLASTIC AGENTS | € 786.70 | skatīt informāciju par zālēm un iepakojumiem |
Not available (according to the information provided by wholesalers) | Prescription (Pr.) | Bevacizumabum Biosimilar medicine |
Vegzelma | Concentrate for solution for infusion | 25 mg/ml |
Not available (according to the information provided by wholesalers) Prescription (Pr.) |
L01FG01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.) | Bevacizumabum Biosimilar medicine |
Vegzelma | Concentrate for solution for infusion | 25 mg/ml |
Not available (according to the information provided by wholesalers) Prescription (Pr.) |
L01FG01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.) | Bevacizumabum Biosimilar medicine |
Vegzelma | Concentrate for solution for infusion | 25 mg/ml |
Not available (according to the information provided by wholesalers) Prescription (Pr.) |
L01FG01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.) | Bevacizumabum Biosimilar medicine |
Vegzelma | Concentrate for solution for infusion | 25 mg/ml |
Not available (according to the information provided by wholesalers) Prescription (Pr.) |
L01FG01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Bevacizumabum Biosimilar medicine |
Zirabev | Concentrate for solution for infusion | 100 mg/4 ml |
Not available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FG01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Bevacizumabum Biosimilar medicine |
Zirabev | Concentrate for solution for infusion | 400 mg/16 ml |
Not available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FG01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem |